Tickers

1. Composite Trajectory Verdict

Given GPGI's transition to a permanent capital platform that accounts for its primary operating subsidiary (Holdings) under the equity method effective February 28, 2025, the balance sheet and cash flow statements carry the most weight for assessing financial trajectory, as the corporate-level income statement now predominantly reflects non‑operating fair‑value changes and equity‑method earnings rather than consolidated operating performance.

Composite Trajectory: Insufficient Data

The annual income statement, cash flow statement, and balance sheet each lack two comparable periods of the same type due to the February 28, 2025 deconsolidation of Holdings. FY2023 and FY2024 reflect full consolidation of Holdings; FY2025 reflects only two months of consolidation followed by ten months of equity‑method accounting, making YoY comparisons invalid. Quarterly data from the four 10‑Q filings (Q2‑Q3 2025, Q1‑Q2 2026) are listed in the document index but their financial statements are not provided in the supplied text, so no quarterly trend can be computed. Without at least two comparable periods for any statement, a trajectory call cannot be made.

2. Red Flags

• Structural break in revenue recognition: Net sales fell from $420.6M (FY2024) to $59.8M (FY2025) solely because Holdings' $402.2M of post‑Spin‑Off sales shifted to equity‑method investment earnings (10-K FY2025, Consolidated Statements of Operations).
• Non‑cash fair‑value swings dominate earnings: Revaluation of warrant liability ($151.0M expense) and earnout consideration liability ($57.1M expense) drove the $212.1M total other expense in FY2025 (10-K FY2025, Consolidated Statements of Operations). Both liabilities were fully settled/extinguished by year‑end 2025 (10-K FY2025, Notes 12).
• Tax receivable agreement liability growing: TRA liability rose from $248.5M (FY2024) to $255.2M (FY2025) despite $5.3M of payments, with a $3.5M remeasurement loss recorded in FY2025 (10-K FY2025, Consolidated Statements of Operations; Note 14).
• Deferred tax asset heavily reliant on TRA: $271.7M net deferred tax asset at FY2025 is primarily driven by the TRA step‑up (IRC 755 intangible assets of $266.3M); realizability depends on future taxable income (10-K FY2025, Note 14).
• Corporate cash flow dependent on Holdings distributions: FY2025 operating cash flow was -$22.9M, but $21.7M came from "Cash receipts from Holdings after the Spin‑Off" (10-K FY2025, Consolidated Statements of Cash Flows). No distributions were received in prior years.

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Insufficient Data

Only two comparable annual periods exist for the pre‑Spin‑Off consolidated structure (FY2023 and FY2024). In those periods, net sales grew 8% YoY ($390.6M to $420.6M), gross margin declined from 54% to 52%, operating margin fell from 30% to 26%, and net income attributable to GPGI swung from +$19.2M to -$53.7M due to $171.8M of non‑cash fair‑value losses on warrants and earnouts (10-K FY2025, Consolidated Statements of Operations). FY2025 is not comparable because the income statement reflects only two months of consolidated operations ($59.8M net sales) plus $128.8M of equity‑method earnings from Holdings for the remaining ten months (10-K FY2025, Consolidated Statements of Operations; Note 6). Quarterly income statements for 2025‑2026 are not available in the provided filings.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Insufficient Data

Comparable annual operating cash flows exist only for FY2023 ($104.3M) and FY2024 ($129.6M), both reflecting consolidated Holdings. FY2025 operating cash flow was -$22.9M, but this includes a $128.8M non‑cash reduction for equity‑method earnings and a $21.7M cash distribution from Holdings (10-K FY2025, Consolidated Statements of Cash Flows). Investing cash flow in FY2025 was -$60.7M, driven by $50.3M of deconsolidated Holdings cash and $10.0M of deconsolidated Resolute cash (10-K FY2025, Consolidated Statements of Cash Flows). Financing cash flow swung from -$83.4M (FY2024) to +$120.8M (FY2025) due to $156.2M of warrant exercises (10-K FY2025, Consolidated Statements of Cash Flows). Quarterly cash flow statements are not provided in the supplied 10‑Q texts.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Insufficient Data

The FY2024 and FY2025 year‑end balance sheets reflect fundamentally different structures. FY2024 shows consolidated Holdings: $473.9M total assets (including $47.4M receivables, $44.8M inventory, $23.4M PP&E), $617.4M total liabilities (including $197.5M term loan, $104.2M warrant liability, $20.5M earnout liability, $248.5M TRA liability), and -$143.4M stockholders' deficit (10-K FY2025, Consolidated Balance Sheets). FY2025 shows post‑deconsolidation: $517.3M total assets (including $114.6M cash, $271.7M deferred tax asset, $125.5M equity‑method investment), $274.1M total liabilities (including $255.2M TRA liability, no debt, no warrant/earnout liabilities), and $243.1M stockholders' equity (10-K FY2025, Consolidated Balance Sheets). The equity‑method investment carrying value ($125.5M) is net of $21.7M distributions received and $128.8M equity earnings (Note 6). Quarterly balance sheets are not provided in the supplied 10‑Q texts.

6. Data Gaps

• Quarterly income statements, cash flow statements, and balance sheets for Q2‑Q3 2025 and Q1‑Q2 2026 (referenced 10‑Q filings not included in the provided text)
• Stand‑alone Holdings financials for the pre‑Spin‑Off period (Jan‑Feb 2025) to bridge the consolidation/equity‑method transition
• Post‑Husky Transaction (closed Jan 12, 2026) consolidated financials for GPGI including Husky operations
• Detailed segment reporting for CompoSecure and Husky businesses under the new platform structure
• Debt maturity schedule and covenant compliance for Holdings' new $2.1B refinancing (closed Jan 14, 2026, described in Note 19 but not quantified in provided tables)